Politiken5h
En lillebitte chip vækker opsigt: »Efterspørgslen ude i verden er nu så stor, at vi har svært ved at følge med«
Hele verden jagter en kvantecomputer, der kan give supercomputere baghjul, når det gælder regnekraft. Nu har et dansk ...
Novo Nordisk will test CagriSema's long-term efficacy in late-stage trial, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
Bloomberg L.P.19h
Novo Nordisk A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...